New Delhi, Feb. 9 -- Zydus Lifesciences announced its financial performance for the quarter ending December today, February 9, reporting a consolidated net profit of Rs.1,042 crore, which remained largely flat compared with a net profit of Rs.1,023 crore, impacted by a sharp rise in operating costs, including one-time provisions such as an Rs.8.5 crore provision related to the implementation of new labour codes.

The Ahmedabad-based drugmaker reported consolidated revenue from operations during the reporting quarter at Rs.6,780 crore, a 30.3% jump over Rs.5,269 crore reported in the same period of the year-ago quarter, on the back of steady India growth, a stronger US portfolio, and surging international sales.

The company said its consu...